SCHEMBL27718554

SCHEMBL27718554

CC(C)(C)NC(=O)OC1CCN(c2ccccc2-c2cccnn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 5/20 0.38
OPRK1 P41145 2/20 0.35
SMO Q99835 1/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
CYP46A1 Q9Y6A2 2/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
CDC42BPB Q9Y5S2 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27718626 0.88 HTR7 (0.47) CHRM3SMOCYP46A1ADRA1DADRA1A
SCHEMBL27644615 0.81 NPC1 (0.39) CHRM3SMOKDM4EALDH1A1
SCHEMBL27790954 0.78 GAA (0.51) CHRM3BCHEACHEKDM4EALDH1A1
SCHEMBL28558686 0.78 HRH3 (0.40) SMOADRA1DADRA1AADRA1BHRH3
SCHEMBL27698093 0.75 HTR7 (0.43) OPRK1ROCK2ROCK1CDC42BPBCYP1A2
SCHEMBL28552653 0.74 CTSB (0.41) SMOADRA1DADRA1AADRA1BALDH1A1
SCHEMBL27769919 0.74 KMT2A (0.46) ALDH1A1
SCHEMBL27643781 0.72 TRPV1 (0.56)
SCHEMBL28896953 0.71 MCHR1 (0.35) CHRM3SMOBCHEKDM4EALDH1A1
SCHEMBL28856275 0.70 GPR119 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101137628-A Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators ASTRAZENECA AB (SE) 2008-03-05 CN disclosed